STONY BROOK, N.Y., October 27, 2006—Iwao Ojima, a Distinguished Professor of Chemistry and Director of the Institute for Chemical Biology and Drug Discovery at Stony Brook University, has been inducted into the Medicinal Chemistry Hall of Fame, which was established this year by the Division of Medicinal Chemistry of the American Chemical Society. According to the announcement, the Hall of Fame recognizes scholars and researchers who have made outstanding contributions to medicinal chemistry through a combination of research, teaching and service.
Dr. Ojima has received the Arthur C. Cope Scholar Award (1994) and Emanuel B. Hershberg Award for Important Discoveries of Medicinally Active Substances (2001) from the American Chemical Society, The Chemical Society of Japan Award (1999) for outstanding achievements from the Chemical Society of Japan, and Outstanding Inventor Award (2002) from the Research Foundation of SUNY. He has been named a Fellow of John S. Guggenheim Memorial Foundation (1995), American Association for Advancement of Science (1997), and New York Academy of Sciences (2000).
He received a Faculty Development Program Award from the New York State Office of Science, Technology & Academic Research (NYSTAR) to establish the Institute of Chemical Biology & Drug Discovery (ICB&DD) as the founding Director in 2003 and started its activity in 2004. The primary objective of ICB&DD is to establish a world-class Center of Excellence in chemical biology and drug discovery at Stony Brook. Under his directorship, ICB&DD has been vigorously promoting highly productive interdisciplinary and collaborative research among chemists, biologists, medicinal chemists, pharmacologists, and physicians to attack major and significant biomedical problems to find breakthroughs and solutions including the discovery of novel therapeutic drugs.
